Oragenics Stock Performance
| OGEN Stock | USD 0.81 0 0.14% |
The company holds a Beta of 0.85, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Oragenics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Oragenics is expected to be smaller as well. At this point, Oragenics has a negative expected return of -0.68%. Please make sure to check Oragenics' information ratio, as well as the relationship between the skewness and price action indicator , to decide if Oragenics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Oragenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:30 | Dividend Date 2018-01-22 | Last Split Date 2025-06-03 |
1 | What MACD trends signal for Oragenics Inc. stock - Trade Exit Report Real-Time Volume Spike Alerts - newser.com | 11/13/2025 |
2 | Will Oragenics Inc. stock maintain momentum in 2025 - 2025 Top Decliners Community Consensus Trade Signals - newser.com | 11/17/2025 |
3 | Will Oragenics Inc. stock reach all time highs in 2025 - Earnings Overview Summary Real-Time Volume Analysis Alerts - B NI V | 11/26/2025 |
4 | Why Oragenics Inc. stock attracts wealthy investors - Analyst Upgrade Consistent Profit Focused Trading Strategies - Newser | 12/04/2025 |
5 | Acquisition by Pope Charles L of 125000 shares of Oragenics at 0.93 subject to Rule 16b-3 | 12/11/2025 |
6 | Disposition of 210 shares by Telling Fred of Oragenics at 0.9446 subject to Rule 16b-3 | 12/12/2025 |
7 | Investment Recap Is Oragenics Inc stock attractive after correction - July 2025 News Drivers Reliable Momentum Entry Alerts - moha.gov.vn | 01/07/2026 |
8 | Aug Chart Watch What is the next catalyst for Oragenics Inc - Weekly Earnings Recap Free Accurate Trade Setup Notifications - baoquankhu1.vn | 01/16/2026 |
9 | Oragenics Extends At-the-Market Equity Sales Agreement - The Globe and Mail | 01/23/2026 |
Oragenics | Build AI portfolio with Oragenics Stock |
Oragenics Relative Risk vs. Return Landscape
If you would invest 129.00 in Oragenics on October 29, 2025 and sell it today you would lose (48.11) from holding Oragenics or give up 37.29% of portfolio value over 90 days. Oragenics is currently does not generate positive expected returns and assumes 4.0451% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Oragenics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Oragenics Target Price Odds to finish over Current Price
The tendency of Oragenics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.81 | 90 days | 0.81 | about 84.13 |
Based on a normal probability distribution, the odds of Oragenics to move above the current price in 90 days from now is about 84.13 (This Oragenics probability density function shows the probability of Oragenics Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Oragenics has a beta of 0.85. This indicates Oragenics market returns are highly reactive to returns on the market. As the market goes up or down, Oragenics is expected to follow. Additionally Oragenics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Oragenics Price Density |
| Price |
Predictive Modules for Oragenics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oragenics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oragenics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oragenics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Oragenics is not an exception. The market had few large corrections towards the Oragenics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oragenics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oragenics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.79 | |
β | Beta against Dow Jones | 0.85 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | -0.2 |
Oragenics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oragenics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oragenics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oragenics generated a negative expected return over the last 90 days | |
| Oragenics has some characteristics of a very speculative penny stock | |
| Oragenics has high historical volatility and very poor performance | |
| Net Loss for the year was (10.57 M) with loss before overhead, payroll, taxes, and interest of (3.39 M). | |
| Oragenics currently holds about 17.87 M in cash with (8.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. | |
| Oragenics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Oragenics Extends At-the-Market Equity Sales Agreement - The Globe and Mail |
Oragenics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oragenics Stock often depends not only on the future outlook of the current and potential Oragenics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oragenics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.6 M | |
| Cash And Short Term Investments | 864.8 K |
Oragenics Fundamentals Growth
Oragenics Stock prices reflect investors' perceptions of the future prospects and financial health of Oragenics, and Oragenics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oragenics Stock performance.
| Return On Equity | -1.69 | ||||
| Return On Asset | -0.71 | ||||
| Current Valuation | (7.65 M) | ||||
| Shares Outstanding | 4.17 M | ||||
| Price To Earning | (2.28) X | ||||
| Price To Book | 0.34 X | ||||
| Price To Sales | 89.28 X | ||||
| Gross Profit | (3.39 M) | ||||
| EBITDA | (10.54 M) | ||||
| Net Income | (10.57 M) | ||||
| Cash And Equivalents | 17.87 M | ||||
| Cash Per Share | 0.15 X | ||||
| Total Debt | 328.53 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 12.31 X | ||||
| Book Value Per Share | 2.38 X | ||||
| Cash Flow From Operations | (8.6 M) | ||||
| Earnings Per Share | 48.21 X | ||||
| Market Capitalization | 3.36 M | ||||
| Total Asset | 1.47 M | ||||
| Retained Earnings | (216.79 M) | ||||
| Working Capital | (211.88 K) | ||||
| Current Asset | 5.64 M | ||||
| Current Liabilities | 1.05 M | ||||
About Oragenics Performance
By examining Oragenics' fundamental ratios, stakeholders can obtain critical insights into Oragenics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Oragenics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 219.24 | 178.02 | |
| Return On Tangible Assets | (8.25) | (7.84) | |
| Return On Capital Employed | 44.85 | 47.09 | |
| Return On Assets | (8.25) | (7.84) | |
| Return On Equity | 44.89 | 47.13 |
Things to note about Oragenics performance evaluation
Checking the ongoing alerts about Oragenics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Oragenics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Oragenics generated a negative expected return over the last 90 days | |
| Oragenics has some characteristics of a very speculative penny stock | |
| Oragenics has high historical volatility and very poor performance | |
| Net Loss for the year was (10.57 M) with loss before overhead, payroll, taxes, and interest of (3.39 M). | |
| Oragenics currently holds about 17.87 M in cash with (8.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. | |
| Oragenics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Oragenics Extends At-the-Market Equity Sales Agreement - The Globe and Mail |
- Analyzing Oragenics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oragenics' stock is overvalued or undervalued compared to its peers.
- Examining Oragenics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Oragenics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oragenics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Oragenics' stock. These opinions can provide insight into Oragenics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.